Endo Int'l Plc (ENDP) 16.88 $ENDP DEADLINE ALERT - ENDO

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Endo Int'l Plc (ENDP) 16.88 $ENDP

DEADLINE ALERT - ENDO INTERNATIONAL plc - Brower Piven Reminds Investors Of Upcoming Deadline And Encourages Shareholders Who Have Losses In Excess Of $100,000 To Contact The Firm - ENDP
GlobeNewswire - Mon Jul 18, 2:42PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Endo International plc (Nasdaq:ENDP) ("Endo" or the "Company" securities during the period between March 2, 2015 and May 6, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 25, 2016 to seek appointment as lead plaintiff.
ENDP: 16.88 (-0.48)

UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Endo International plc and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Jul 18, 12:51PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 18, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company" (NASDAQ: ENDP) concerning possible violations of federal securities laws between March 2, 2015 and May 6, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 25, 2016 lead plaintiff motion deadline.
ENDP: 16.88 (-0.48)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Endo International plc of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 25, 2016 - ENDP
GlobeNewswire - Mon Jul 18, 9:41AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ENDP: 16.88 (-0.48)

Endo to Announce Second Quarter 2016 Financial Results on August 8, 2016
PR Newswire Europe - Mon Jul 18, 6:30AM CDT
Endo International plc will announce its second quarter 2016 financial results after the close of the U.S. financial markets on August 8, 2016 and members of its senior management team will host a conference call and webcast at 4:30 p.m. ET that day.
ENDP: 16.88 (-0.48), ENL.TO: 22.85 (-0.82)

JULY 25, 2016 DEADLINE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Endo International plc And Encourages Investors With Losses To Contact The Firm
ACCESSWIRE - Mon Jul 18, 4:31AM CDT
IRVINE, CA / ACCESSWIRE / July 18, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company" (NASDAQ: ENDP). Investors who purchased or otherwise acquired shares between March 2, 2015 and May 6, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 25, 2016 lead plaintiff motion deadline.
ENDP: 16.88 (-0.48)

GPM Reminds Investors of the July 25 Deadline in the Class Action Lawsuit Against Endo International plc
BusinessWire - Fri Jul 15, 2:03PM CDT
Glancy Prongay & Murray LLP ("GPM" reminds investors of the July 25, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class" of investors who purchased Endo International plc ("Endo International" or the "Company" (NASDAQ: ENDP) securities between March 2, 2015 and May 6, 2016, inclusive (the "Class Period". Endo International investors have until July 25, 2016 to file a lead plaintiff motion.
ENDP: 16.88 (-0.48)

SmarTrend Watching for Potential Pullback in Shares of Endo Pharmaceuticals After 2.42% Gain
Comtex SmarTrend(R) - Wed Jul 13, 12:17PM CDT
Endo Pharmaceuticals (NASDAQ:ENDP) traded in a range yesterday that spanned from a low of $17.57 to a high of $18.62. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $17.83 on volume of 4.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ENDP: 16.88 (-0.48)

INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Endo International plc And Reminds Investors With Losses to Contact the Firm
ACCESSWIRE - Wed Jul 13, 11:09AM CDT
LOS ANGELES, CA / ACCESWIRE / July 13, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company" (NASDAQ: ENDP) concerning possible violations of federal securities laws between March 2, 2015 and May 6, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 25, 2016 lead plaintiff motion deadline.
ENDP: 16.88 (-0.48)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action against Endo International plc (ENDP) and Lead Plaintiff Deadline: July 25, 2016
ACCESSWIRE - Wed Jul 13, 9:07AM CDT
NEW YORK, NY / ACCESSWIRE / July 13, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed in the United States District Court, Southern District of New York on behalf of those who purchased shares of Endo International plc ("Endo" or the "Company" (NASDAQ: ENDP) between March 2, 2015 and May 6, 2016 inclusive (the "Class Period".
ENDP: 16.88 (-0.48)

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Endo International plc And Encourages Investors With Losses To Contact The Firm
ACCESSWIRE - Tue Jul 12, 8:28PM CDT
IRVINE, CA / ACCESSWIRE / July 12, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company" (Nasdaq: ENDP). Investors who purchased or otherwise acquired shares between March 2, 2015 and May 6, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 25, 2016 lead plaintiff motion deadline.
ENDP: 16.88 (-0.48)

Testosterone Replacement Therapy (TRT) Market to Face Lean Patch until 2024 as it Inches Close to Patent Cliff, Says TMR
PR Newswire Europe - Tue Jul 12, 11:31AM CDT
ALBANY, New York, July 12, 2016 /PRNewswire/ --
AGN: 254.86 (+1.91), ENDP: 16.88 (-0.48), LLY: 83.18 (+0.29), ABBV: 66.94 (+0.71)

ENDO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Endo International plc - ENDP
PR Newswire - Fri Jul 08, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 25, 2016 to file lead plaintiff applications in a securities class action lawsuit against Endo International plc (NasdaqGS: ENDP), if they purchased the Company's securities between March 2, 2015 and May 6, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Southern District of New York.
ENDP: 16.88 (-0.48)

Microchip Technology Incorporated to Join the NASDAQ-100 Index Beginning July 18, 2016
GlobeNewswire - Fri Jul 08, 7:00PM CDT
Nasdaq (Nasdaq:NDAQ) today announced that Microchip Technology Incorporated (Nasdaq:MCHP), will become a component of the NASDAQ-100 Index(R) (Nasdaq:NDX) and the NASDAQ-100 Equal Weighted Index (Nasdaq:NDXE) prior to market open on Monday, July 18, 2016. Microchip Technology Incorporated will replace Endo International plc (Nasdaq:ENDP) in the indexes.
ENDP: 16.88 (-0.48), MCHP: 55.81 (+0.17), NDAQ: 71.42 (+0.66)

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Endo International plc Of Upcoming Deadline
GlobeNewswire - Fri Jul 08, 6:00AM CDT
Rigrodsky & Long, P.A.:
ENDP: 16.88 (-0.48)

JULY 25, 2016 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Endo International plc and Reminds Investors with Losses to Contact the Firm
BusinessWire - Thu Jul 07, 7:26PM CDT
Lundin Law PC announces a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company" (Nasdaq: ENDP) concerning possible violations of federal securities laws between March 2, 2015 and May 6, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 25, 2016 lead plaintiff motion deadline.
ENDP: 16.88 (-0.48)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Endo International plc and a Lead Plaintiff Deadline of July 25, 2016
BusinessWire - Fri Jun 24, 10:26AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Endo International plc (NASDAQ:ENDP) securities between March 2, 2015 and May 6, 2016.
ENDP: 16.88 (-0.48)

Watch for Endo Pharmaceuticals to Potentially Rebound After Falling 5.41% Yesterday
Comtex SmarTrend(R) - Tue Jun 21, 1:44PM CDT
Endo Pharmaceuticals (NASDAQ:ENDP) traded in a range yesterday that spanned from a low of $14.88 to a high of $16.14. Yesterday, the shares fell 5.4%, which took the trading range below the 3-day low of $16.05 on volume of 4.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ENDP: 16.88 (-0.48)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 2

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 2

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 2

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 4

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Halozyme's Upcoming Investment Presentation at Healthcare Conference

Updated Category News Views 277

Halozyme's Participation in Major Healthcare Conference Halozyme Therapeutics, Inc. (NASDAQ: HALO) is set to showcase its advancements at an important healthcare conference. Dr. Helen Torley, the president and CEO, will present and engage in investor meetings, highlighting the company's innovative approaches in the biopharmaceutical sector. Details of the Presentation The...

Continue Reading
Revitalizing Everyday Sound: viaim's Collaboration with Orchestra

Updated Category News Views 181

Transforming Everyday Listening through Technology In an exciting development for audio enthusiasts, viaim, an innovative AI audio brand, has joined forces with the prestigious China Philharmonic Orchestra. This dynamic collaboration has given birth to the "Philharmonic Signature Sound," an advanced acoustic system meticulously designed to replicate the immersive...

Continue Reading
Unlocking the Future of Payments: Early Access for Wirex Pay Users

Updated Category News Views 103

Wirex Pay Revolutionizes Crypto Payments with Early Access Wirex Pay, a groundbreaking decentralized payment network, is thrilled to announce its innovative crypto payment application is now available for early access to select users. This opportunity marks a significant step towards the next wave of digital transactions, integrating cryptocurrencies into everyday...

Continue Reading
Inspire Investing Introduces New Fund Names for Better Clarity

Updated Category News Views 172

Inspire Investing Reveals Name Changes for ETFs Inspire Investing, renowned as the largest provider of faith-based ETFs, has announced significant updates to the names of two of its exchange-traded funds. These changes, aimed at increasing clarity regarding the funds' investment strategies, reflect Inspire's commitment to aligning their product offerings with investor...

Continue Reading
BASF's Recent Challenges Impact Earnings and Cash Flow Performance

Updated Category News Views 105

BASF Faces Headwinds in Latest Earnings Report Shares of BASF SE (OTC: BASFY) decreased by 2% following the publication of its third-quarter results. The company struggled to meet expectations across various divisions despite evidence of resilience in specific areas. Financial Performance Analysis BASF reported an adjusted EBITDA of €1,622 million, which is a notable 3%...

Continue Reading